GLS Pharma Limited
Indian Pharmaceutical Exporter ยท Oncology Specialist ยท $198.8K Total Trade ยท DGFT Verified
GLS Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $198.8K across 4 products in 2 therapeutic categories. Based on 45 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Cyclophosphamide ($120.3K), Ifosfamide ($47.8K), Busulfan ($18.4K).
GLS Pharma Limited โ Export Portfolio & Destination Treemap

Who is GLS Pharma Limited? โ Company Overview & Market Position
GLS Pharma Limited, established on September 1, 2004, is a professionally managed pharmaceutical company headquartered in New Delhi, India. The company specializes in the manufacturing and marketing of oncology and chemotherapy-related products, including chemotherapy, hematology, supportive care, and novel drug delivery systems (NDDS). GLS Pharma has a significant presence in the Indian pharmaceutical market, exporting its products to over 30 countries.
The company operates as a public limited entity with an authorized capital of โน13 million and a paid-up capital of โน12 million. As of April 3, 2024, GLS Pharma employed 116 professionals. In June 2022, GLS Pharma was acquired by Aurobindo Pharma, a leading Indian pharmaceutical company, enhancing its capabilities and market reach.